Theranos Serves as a Cautionary Tale for Biotech Funding Post author:Sam Post published:March 15, 2018 Post category:BioPharma There are dangers in biotech funding and Theranos should serve as a warning. Source: BioSpace You Might Also Like Takeda's $5 Billion Bet on Ariad Pays Off With Accelerated Approval of Lung Cancer Med April 30, 2017 Immune Pharma Appoints New Chairman Of The Board Of Directors January 26, 2017 Sangamo Scores Bragging Rights for First-in-Human Gene Editing Trial November 14, 2017
Takeda's $5 Billion Bet on Ariad Pays Off With Accelerated Approval of Lung Cancer Med April 30, 2017
